Order Article Reprints

Viscuse PV, Slack-Tidwell RS, Zhang M, Rohra P, Zhu K, San Lucas FA, Konnick E, Pilie PG, Siddiqui B, Logothetis CJ, et al. Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments. Cancers. 2023; 15(24):5843. https://doi.org/10.3390/cancers15245843

Viscuse, Paul V., Rebecca S. Slack-Tidwell, Miao Zhang, Prih Rohra, Keyi Zhu, F. Anthony San Lucas, Eric Konnick, Patrick G. Pilie, Bilal Siddiqui, Christopher J. Logothetis, and et al. 2023. "Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments" Cancers 15, no. 24: 5843. https://doi.org/10.3390/cancers15245843

Viscuse, P. V., Slack-Tidwell, R. S., Zhang, M., Rohra, P., Zhu, K., San Lucas, F. A., Konnick, E., Pilie, P. G., Siddiqui, B., Logothetis, C. J., Corn, P., Subudhi, S. K., Pritchard, C. C., Soundararajan, R., & Aparicio, A. (2023). Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments. Cancers, 15(24), 5843. https://doi.org/10.3390/cancers15245843